amobarbital has been researched along with Astrocytosis in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, RR | 1 |
| Alexopoulos, AV | 1 |
| Loddenkemper, T | 1 |
| Davies, KG | 1 |
| Hermann, BP | 1 |
| Foley, KT | 1 |
2 other studies available for amobarbital and Astrocytosis
| Article | Year |
|---|---|
Incidence and clinical decision making for the Wada test over one decade: 1997-2007.
Topics: Adolescent; Adult; Aged; Amobarbital; Child; Child, Preschool; Electrodes, Implanted; Epilepsy, Temp | 2010 |
Relation between intracarotid amobarbital memory asymmetry scores and hippocampal sclerosis in patients undergoing anterior temporal lobe resections.
Topics: Adolescent; Adult; Amobarbital; Epilepsy; Female; Functional Laterality; Gliosis; Hippocampus; Human | 1996 |